"biogen" - Google News

Biogen to pay $18.9 million to settle investors' claims over Alzheimer's drug - Reuters

Mon, 08 Jun 2026 15:47:44 GMT

Biogen to pay $18.9 million to settle investors' claims over Alzheimer's drug Reuters

UCB and Biogen Announce Publication in The Lancet of Positive Dapirolizumab Pegol (DZP) Phase 3 Study Results in Systemic Lupus Erythematosus - Biogen

Mon, 01 Jun 2026 07:00:00 GMT

UCB and Biogen Announce Publication in The Lancet of Positive Dapirolizumab Pegol (DZP) Phase 3 Study Results in Systemic Lupus Erythematosus Biogen

Lilly, Biogen, Eisai and Genentech sponsor Alzheimer’s podcast - Fierce Pharma

Fri, 12 Jun 2026 13:09:27 GMT

Lilly, Biogen, Eisai and Genentech sponsor Alzheimer’s podcast Fierce Pharma

How Is Biogen’s Stock Performance Compared to Other Biotech Stocks? - Yahoo Finance

Wed, 10 Jun 2026 11:06:26 GMT

How Is Biogen’s Stock Performance Compared to Other Biotech Stocks? Yahoo Finance

BIIB Investors Have Opportunity to Join Biogen Inc. Fraud Investigation with the Schall Law Firm - GlobeNewswire

Wed, 10 Jun 2026 14:29:09 GMT

BIIB Investors Have Opportunity to Join Biogen Inc. Fraud Investigation with the Schall Law Firm GlobeNewswire

Biogen completes acquisition of Apellis Pharmaceuticals - Ophthalmology Times

Mon, 18 May 2026 07:00:00 GMT

Biogen completes acquisition of Apellis Pharmaceuticals Ophthalmology Times

Parkinson’s drug from Biogen, Denali comes up short - BioPharma Dive

Fri, 22 May 2026 07:00:00 GMT

Parkinson’s drug from Biogen, Denali comes up short BioPharma Dive

Biogen, Denali pull plug on Parkinson’s program after mid-stage flop - BioSpace

Fri, 22 May 2026 07:00:00 GMT

Biogen, Denali pull plug on Parkinson’s program after mid-stage flop BioSpace

Biogen advances Alzheimer's drug to late-stage trial despite disappointing data - CNBC

Thu, 14 May 2026 07:00:00 GMT

Biogen advances Alzheimer's drug to late-stage trial despite disappointing data CNBC

Biogen Announces Upcoming Kidney Presentations at European Renal Association and American Transplant Congresses - Biogen

Wed, 03 Jun 2026 11:36:51 GMT

Biogen Announces Upcoming Kidney Presentations at European Renal Association and American Transplant Congresses Biogen

Biogen investigated by Italian regulator over multiple sclerosis ‘market abuse’ claims - Fierce Pharma

Wed, 27 May 2026 07:00:00 GMT

Biogen investigated by Italian regulator over multiple sclerosis ‘market abuse’ claims Fierce Pharma

Italy probes Biogen for allegedly hindering sales of rival's MS drug - Reuters

Wed, 27 May 2026 07:00:00 GMT

Italy probes Biogen for allegedly hindering sales of rival's MS drug Reuters

Biogen’s Salanersen Receives FDA Breakthrough Therapy Designation for Spinal Muscular Atrophy - Biogen

Thu, 04 Jun 2026 07:00:00 GMT

Biogen’s Salanersen Receives FDA Breakthrough Therapy Designation for Spinal Muscular Atrophy Biogen

Biogen, Denali scrap Parkinson's drug after failure in mid-to-late stage study - Reuters

Thu, 21 May 2026 07:00:00 GMT

Biogen, Denali scrap Parkinson's drug after failure in mid-to-late stage study Reuters

Update on FDA Priority Review of LEQEMBI® IQLIK™ (lecanemab-irmb) Subcutaneous Injection as a Starting Dose for Early Alzheimer’s Disease - Biogen

Fri, 08 May 2026 07:00:00 GMT

Update on FDA Priority Review of LEQEMBI® IQLIK™ (lecanemab-irmb) Subcutaneous Injection as a Starting Dose for Early Alzheimer’s Disease Biogen

Biogen Completes Acquisition of Apellis Pharmaceuticals - Biogen

Thu, 14 May 2026 07:00:00 GMT

Biogen Completes Acquisition of Apellis Pharmaceuticals Biogen

Biogen to Acquire Apellis, Enhancing the Company’s Growth Portfolio in Immunology and Rare Disease, Bolstering Growth Outlook and Accelerating Expansion into Nephrology - Biogen

Tue, 31 Mar 2026 07:00:00 GMT

Biogen to Acquire Apellis, Enhancing the Company’s Growth Portfolio in Immunology and Rare Disease, Bolstering Growth Outlook and Accelerating Expansion into Nephrology Biogen

Driving Impact in Rare Disease: A Q&A with Eléonore Dubois - Biogen

Tue, 02 Jun 2026 07:00:00 GMT

Driving Impact in Rare Disease: A Q&A with Eléonore Dubois Biogen

FDA Approves New High Dose Regimen of SPINRAZA® (nusinersen) for Spinal Muscular Atrophy - Biogen

Mon, 30 Mar 2026 07:00:00 GMT

FDA Approves New High Dose Regimen of SPINRAZA® (nusinersen) for Spinal Muscular Atrophy Biogen

Leading the way across the blood–brain barrier - Biogen

Thu, 02 Apr 2026 07:00:00 GMT

Leading the way across the blood–brain barrier Biogen

Biogen Announces Second Positive Phase 2 Litifilimab Trial in Cutaneous Lupus Erythematosus at 2026 American Academy of Dermatology Annual Meeting, Showing a Significant Reduction in Skin Disease Activity - Biogen

Sat, 28 Mar 2026 07:00:00 GMT

Biogen Announces Second Positive Phase 2 Litifilimab Trial in Cutaneous Lupus Erythematosus at 2026 American Academy of Dermatology Annual Meeting, Showing a Significant Reduction in Skin Disease Activity Biogen

Biogen and Denali report Phase IIb LUMA trial data for Parkinson’s - Clinical Trials Arena

Fri, 22 May 2026 07:00:00 GMT

Biogen and Denali report Phase IIb LUMA trial data for Parkinson’s Clinical Trials Arena

Biogen’s tau-targeting Alzheimer’s drug posts mixed results in mid-stage study - statnews.com

Thu, 14 May 2026 07:00:00 GMT

Biogen’s tau-targeting Alzheimer’s drug posts mixed results in mid-stage study statnews.com

Biogen Presents Additional Salanersen Data Showing New Motor Milestones Achieved in Children with SMA Previously Treated with Gene Therapy - Biogen

Wed, 11 Mar 2026 07:00:00 GMT

Biogen Presents Additional Salanersen Data Showing New Motor Milestones Achieved in Children with SMA Previously Treated with Gene Therapy Biogen

From Commissioning to Collaboration: Neil’s Journey at Biogen Solothurn - Biogen

Thu, 21 May 2026 07:00:00 GMT

From Commissioning to Collaboration: Neil’s Journey at Biogen Solothurn Biogen

Biogen to advance experimental Alzheimer's drug despite mid-stage trial miss - Reuters

Thu, 14 May 2026 07:00:00 GMT

Biogen to advance experimental Alzheimer's drug despite mid-stage trial miss Reuters

Biogen Stock (BIIB) Opinions on Congressional Purchases and Analyst Upgrade - Moomoo

Tue, 09 Jun 2026 17:33:10 GMT

Biogen Stock (BIIB) Opinions on Congressional Purchases and Analyst Upgrade Moomoo

Biogen to Participate in the Bank of America Securities 2026 Health Care Conference - Biogen

Tue, 05 May 2026 07:00:00 GMT

Biogen to Participate in the Bank of America Securities 2026 Health Care Conference Biogen

Biogen advances Alzheimer’s tau program despite midphase miss - Fierce Biotech

Thu, 14 May 2026 07:00:00 GMT

Biogen advances Alzheimer’s tau program despite midphase miss Fierce Biotech

Biogen Announces Board Chair Transition - Biogen

Wed, 11 Feb 2026 08:00:00 GMT

Biogen Announces Board Chair Transition Biogen

Building on Three Decades of U.S. Manufacturing - Biogen

Tue, 28 Apr 2026 07:00:00 GMT

Building on Three Decades of U.S. Manufacturing Biogen

A Look At Biogen (BIIB) Valuation After New Breakthrough SMA Nod And Positive Lupus Phase 3 Data - Yahoo Finance

Fri, 05 Jun 2026 07:00:00 GMT

A Look At Biogen (BIIB) Valuation After New Breakthrough SMA Nod And Positive Lupus Phase 3 Data Yahoo Finance

Maria Elvira Salazar invests in Biogen, Datadog and IBM; sells Sherwin-Williams and Whirlpool stocks By Investing.com - Investing.com

Wed, 10 Jun 2026 00:24:20 GMT

Maria Elvira Salazar invests in Biogen, Datadog and IBM; sells Sherwin-Williams and Whirlpool stocks By Investing.com Investing.com

Advancing Lupus Research Through Patient-First, Data-Driven Design - Biogen

Tue, 28 Apr 2026 07:00:00 GMT

Advancing Lupus Research Through Patient-First, Data-Driven Design Biogen

Bristol Myers’ legacy lift, Biogen’s blue skies and Regeneron’s murky outlook - BioPharma Dive

Fri, 01 May 2026 07:00:00 GMT

Bristol Myers’ legacy lift, Biogen’s blue skies and Regeneron’s murky outlook BioPharma Dive

Should Biogen’s (BIIB) New SMA Breakthrough and Lupus Data Prompt a Fresh Look From Investors? - Yahoo Finance

Fri, 05 Jun 2026 07:00:00 GMT

Should Biogen’s (BIIB) New SMA Breakthrough and Lupus Data Prompt a Fresh Look From Investors? Yahoo Finance

Driving Progress in Nephrology: Carmelina’s Journey - Biogen

Thu, 21 May 2026 07:00:00 GMT

Driving Progress in Nephrology: Carmelina’s Journey Biogen

Biogen to Present at the 44th Annual J.P. Morgan Healthcare Conference - Biogen

Tue, 06 Jan 2026 08:00:00 GMT

Biogen to Present at the 44th Annual J.P. Morgan Healthcare Conference Biogen

Biogen to Present New Late-Breaking Litifilimab Phase 2 AMETHYST Data in Cutaneous Lupus Erythematosus at 2026 American Academy of Dermatology Annual Meeting - Biogen

Thu, 19 Mar 2026 07:00:00 GMT

Biogen to Present New Late-Breaking Litifilimab Phase 2 AMETHYST Data in Cutaneous Lupus Erythematosus at 2026 American Academy of Dermatology Annual Meeting Biogen

Jessica & Ashley’s Story: Mother and Daughter Navigate Kidney Transplant Rejection - Biogen

Tue, 03 Mar 2026 08:00:00 GMT

Jessica & Ashley’s Story: Mother and Daughter Navigate Kidney Transplant Rejection Biogen

Biogen pushing tau drug forward despite Alzheimer’s study failure - BioPharma Dive

Thu, 14 May 2026 07:00:00 GMT

Biogen pushing tau drug forward despite Alzheimer’s study failure BioPharma Dive

Needham upgrades Biogen stock rating on pipeline outlook - Investing.com

Mon, 08 Jun 2026 12:08:21 GMT

Needham upgrades Biogen stock rating on pipeline outlook Investing.com

Building a Future for Lupus Patients: A Q&A with Brenda Leonard - Biogen

Tue, 24 Mar 2026 07:00:00 GMT

Building a Future for Lupus Patients: A Q&A with Brenda Leonard Biogen

Is Biogen Inc (BIIB) Overvalued After 3.4% Rally? GF Value Says - GuruFocus

Tue, 09 Jun 2026 23:15:00 GMT

Is Biogen Inc (BIIB) Overvalued After 3.4% Rally? GF Value Says GuruFocus

Living with CLE, a form of lupus: Nandan’s Story - Biogen

Tue, 24 Mar 2026 07:00:00 GMT

Living with CLE, a form of lupus: Nandan’s Story Biogen

Biogen axes Denali-partnered Parkinson’s prospect after phase 2 flop - Fierce Biotech

Fri, 22 May 2026 07:00:00 GMT

Biogen axes Denali-partnered Parkinson’s prospect after phase 2 flop Fierce Biotech

Why Is Biogen (BIIB) Up 3.8% Since Last Earnings Report? - Yahoo Finance

Fri, 29 May 2026 07:00:00 GMT

Why Is Biogen (BIIB) Up 3.8% Since Last Earnings Report? Yahoo Finance

Biogen’s Litifilimab Receives FDA Breakthrough Therapy Designation for Cutaneous Lupus Erythematosus, a Disease With No Targeted Treatment Options - Biogen

Wed, 28 Jan 2026 08:00:00 GMT

Biogen’s Litifilimab Receives FDA Breakthrough Therapy Designation for Cutaneous Lupus Erythematosus, a Disease With No Targeted Treatment Options Biogen

Biogen Inc. (BIIB) Gets Upgraded by UBS on Upcoming Pipeline Catalysts - Yahoo Finance

Sun, 26 Apr 2026 07:00:00 GMT

Biogen Inc. (BIIB) Gets Upgraded by UBS on Upcoming Pipeline Catalysts Yahoo Finance

Biogen's Base Is Declining — But 8 Pipeline Readouts Could Flip The Story - Benzinga

Mon, 08 Jun 2026 16:08:44 GMT

Biogen's Base Is Declining — But 8 Pipeline Readouts Could Flip The Story Benzinga

Biogen’s Salanersen Earns FDA Breakthrough Therapy Designation for SMA - BioPharm International

Thu, 04 Jun 2026 16:13:49 GMT

Biogen’s Salanersen Earns FDA Breakthrough Therapy Designation for SMA BioPharm International

Biogen’s Nicole Murphy Aims to Elevate the Manufacturing Workforce - National Association of Manufacturers - NAM

Tue, 19 May 2026 07:00:00 GMT

Biogen’s Nicole Murphy Aims to Elevate the Manufacturing Workforce National Association of Manufacturers - NAM

Shaping the Future of Lupus Care: Youmna Lahoud, MD - Biogen

Mon, 20 Apr 2026 07:00:00 GMT

Shaping the Future of Lupus Care: Youmna Lahoud, MD Biogen

Biogen inks $850M biobucks deal with TJ Biopharma for China rights to late-stage immune antibody - Fierce Biotech

Mon, 20 Apr 2026 07:00:00 GMT

Biogen inks $850M biobucks deal with TJ Biopharma for China rights to late-stage immune antibody Fierce Biotech

Biogen beats profit expectations as demand for newer rare-disease drugs fuel growth - Reuters

Wed, 29 Apr 2026 07:00:00 GMT

Biogen beats profit expectations as demand for newer rare-disease drugs fuel growth Reuters

Biogen Ends BIIB122 Parkinsons Trial And Refocuses Neurodegeneration Pipeline - Yahoo Finance

Tue, 02 Jun 2026 07:00:00 GMT

Biogen Ends BIIB122 Parkinsons Trial And Refocuses Neurodegeneration Pipeline Yahoo Finance

Biogen Secures ‘Running Start’ in Kidney Disease With $5.6B Apellis Buy - BioSpace

Tue, 31 Mar 2026 07:00:00 GMT

Biogen Secures ‘Running Start’ in Kidney Disease With $5.6B Apellis Buy BioSpace

Biogen (BIIB) Stock Trades Up, Here Is Why - Yahoo Finance

Mon, 20 Apr 2026 07:00:00 GMT

Biogen (BIIB) Stock Trades Up, Here Is Why Yahoo Finance

This Biogen Analyst Turns Bullish; Here Are Top 3 Upgrades For Monday - Benzinga

Mon, 08 Jun 2026 13:58:05 GMT

This Biogen Analyst Turns Bullish; Here Are Top 3 Upgrades For Monday Benzinga

Biogen Price Target Announced at $255.00/Share by Needham - Moomoo

Mon, 08 Jun 2026 10:45:00 GMT

Biogen Price Target Announced at $255.00/Share by Needham Moomoo

Biogen has seen enough — despite no dose response — to advance tau-directed therapy - FirstWord Pharma

Thu, 14 May 2026 07:00:00 GMT

Biogen has seen enough — despite no dose response — to advance tau-directed therapy FirstWord Pharma

Diana Gallagher, MD: The Intersection of Biology and Humanity - Biogen

Tue, 10 Feb 2026 22:17:52 GMT

Diana Gallagher, MD: The Intersection of Biology and Humanity Biogen

Biogen Enters into Agreement with TJ Biopharma for Felzartamab Assets in the Greater China Region - GlobeNewswire

Mon, 20 Apr 2026 07:00:00 GMT

Biogen Enters into Agreement with TJ Biopharma for Felzartamab Assets in the Greater China Region GlobeNewswire

Biogen, on the heels of a $5.6B buyout, turns its sights to early-stage assets - BioPharma Dive

Wed, 01 Apr 2026 07:00:00 GMT

Biogen, on the heels of a $5.6B buyout, turns its sights to early-stage assets BioPharma Dive

Biogen takes tau Alzheimer’s therapy to Phase 3 despite mid-stage fail, prompting cautious optimism - BioSpace

Thu, 14 May 2026 07:00:00 GMT

Biogen takes tau Alzheimer’s therapy to Phase 3 despite mid-stage fail, prompting cautious optimism BioSpace

Biogen Inc. Q1 2026 Earnings Call Summary - Yahoo Finance

Wed, 29 Apr 2026 07:00:00 GMT

Biogen Inc. Q1 2026 Earnings Call Summary Yahoo Finance

Biogen to Acquire Apellis for $5.6B to Strengthen Immunology Portfolio - Yahoo Finance

Wed, 01 Apr 2026 07:00:00 GMT

Biogen to Acquire Apellis for $5.6B to Strengthen Immunology Portfolio Yahoo Finance

Biogen settles investor lawsuit over its messaging on failed Alzheimer's drug Aduhelm - Fierce Pharma

Wed, 08 Apr 2026 07:00:00 GMT

Biogen settles investor lawsuit over its messaging on failed Alzheimer's drug Aduhelm Fierce Pharma

This House of Representative Just Bought Up To $375K In Biogen Stock - Benzinga

Tue, 09 Jun 2026 15:15:39 GMT

This House of Representative Just Bought Up To $375K In Biogen Stock Benzinga

Biogen uplifts rare disease pipeline with $5.6bn Apellis buyout - Pharmaceutical Technology

Wed, 01 Apr 2026 07:00:00 GMT

Biogen uplifts rare disease pipeline with $5.6bn Apellis buyout Pharmaceutical Technology

Biogen seeks Darzalex rivalry in China for multiple myeloma with felzartamab deal - Pharmaceutical Technology

Fri, 24 Apr 2026 07:00:00 GMT

Biogen seeks Darzalex rivalry in China for multiple myeloma with felzartamab deal Pharmaceutical Technology

Biogen, with $5.6B Apellis buy, builds out immunology offerings - BioPharma Dive

Tue, 31 Mar 2026 07:00:00 GMT

Biogen, with $5.6B Apellis buy, builds out immunology offerings BioPharma Dive

Biogen’s Alzheimer’s results bolster tau theory—and Denali’s next gen candidate - BioSpace

Fri, 15 May 2026 07:00:00 GMT

Biogen’s Alzheimer’s results bolster tau theory—and Denali’s next gen candidate BioSpace

FDA Action Alert: Argenx, AstraZeneca/Daiichi Sankyo, Biogen/Eisai and Cingulate - BioSpace

Mon, 04 May 2026 07:00:00 GMT

FDA Action Alert: Argenx, AstraZeneca/Daiichi Sankyo, Biogen/Eisai and Cingulate BioSpace

Biogen Stock Slides After Trial Miss, But Analysts Stay Bullish - Yahoo Finance

Fri, 22 May 2026 07:00:00 GMT

Biogen Stock Slides After Trial Miss, But Analysts Stay Bullish Yahoo Finance

How New Chillers Are Turning Down the Heat on Energy Use - Biogen

Tue, 28 Apr 2026 07:00:00 GMT

How New Chillers Are Turning Down the Heat on Energy Use Biogen

Bulls and Biogen Team Up to Celebrate "America 250" with Triangle Community - MLB.com

Thu, 16 Apr 2026 07:00:00 GMT

Bulls and Biogen Team Up to Celebrate "America 250" with Triangle Community MLB.com

Living with Alzheimer’s Disease: Lance’s Story - Biogen

Wed, 13 May 2026 07:00:00 GMT

Living with Alzheimer’s Disease: Lance’s Story Biogen

Biogen to buy Apellis Pharmaceuticals for $5.6 billion in rare disease push - CNBC

Tue, 31 Mar 2026 07:00:00 GMT

Biogen to buy Apellis Pharmaceuticals for $5.6 billion in rare disease push CNBC

Decoding disease with biomarkers - Biogen

Mon, 04 May 2026 07:00:00 GMT

Decoding disease with biomarkers Biogen

UCB and Biogen Announce Publication in The Lancet of - GlobeNewswire

Mon, 01 Jun 2026 07:00:00 GMT

UCB and Biogen Announce Publication in The Lancet of GlobeNewswire

Biogen’s Lupus Drug Reduces Disease Activity, Further Deresking I&I Pipeline - BioSpace

Mon, 30 Mar 2026 07:00:00 GMT

Biogen’s Lupus Drug Reduces Disease Activity, Further Deresking I&I Pipeline BioSpace

Biogen Faces Trial Setbacks And Probes That Reframe Neuro Pipeline Risks - Yahoo Finance

Fri, 22 May 2026 07:00:00 GMT

Biogen Faces Trial Setbacks And Probes That Reframe Neuro Pipeline Risks Yahoo Finance

BIIB Investors Have Opportunity to Join Biogen Inc. Fraud Investigation with the Schall Law Firm - Business Wire

Fri, 05 Jun 2026 00:58:00 GMT

BIIB Investors Have Opportunity to Join Biogen Inc. Fraud Investigation with the Schall Law Firm Business Wire

Nature Medicine Publishes Results from the Pivotal DEVOTE Study of High-Dose Regimen of Nusinersen in Spinal Muscular Atrophy - Biogen

Wed, 04 Feb 2026 08:00:00 GMT

Nature Medicine Publishes Results from the Pivotal DEVOTE Study of High-Dose Regimen of Nusinersen in Spinal Muscular Atrophy Biogen

Biogen links up with Alloy platform to boost ASO drug development - Fierce Biotech

Tue, 07 Apr 2026 07:00:00 GMT

Biogen links up with Alloy platform to boost ASO drug development Fierce Biotech

Biogen buys China rights to immune disease drug in up to $850 million deal with TJ Biopharma - Reuters

Mon, 20 Apr 2026 07:00:00 GMT

Biogen buys China rights to immune disease drug in up to $850 million deal with TJ Biopharma Reuters

Biogen Receives European Commission Approval for High Dose Regimen of SPINRAZA® (nusinersen) for Spinal Muscular Atrophy - Biogen

Mon, 12 Jan 2026 08:00:00 GMT

Biogen Receives European Commission Approval for High Dose Regimen of SPINRAZA® (nusinersen) for Spinal Muscular Atrophy Biogen

Needham Upgrades Biogen to Buy From Hold, Price Target Is $255 - Moomoo

Mon, 08 Jun 2026 10:52:15 GMT

Needham Upgrades Biogen to Buy From Hold, Price Target Is $255 Moomoo

Sarah Kleinpeter: Driving the Future of Alzheimer's Care - Biogen

Tue, 02 Dec 2025 08:00:00 GMT

Sarah Kleinpeter: Driving the Future of Alzheimer's Care Biogen

Biogen to acquire Apellis for $5.6bn - Financier Worldwide

Tue, 12 May 2026 14:57:21 GMT

Biogen to acquire Apellis for $5.6bn Financier Worldwide

Biogen Q1 Earnings: Can New Launches Offset Declining MS Franchise? - Yahoo Finance

Fri, 24 Apr 2026 07:00:00 GMT

Biogen Q1 Earnings: Can New Launches Offset Declining MS Franchise? Yahoo Finance

Denali Stock Dips as Biogen-Partnered Parkinson's Disease Study Fails - Yahoo Finance

Fri, 22 May 2026 07:00:00 GMT

Denali Stock Dips as Biogen-Partnered Parkinson's Disease Study Fails Yahoo Finance

Biogen, eyeing swift commercial tailwind, ponies up $5.6B for Apellis and its 2 approved meds - Fierce Pharma

Tue, 31 Mar 2026 07:00:00 GMT

Biogen, eyeing swift commercial tailwind, ponies up $5.6B for Apellis and its 2 approved meds Fierce Pharma

Biogen to acquire immunology biotech Apellis for $5.6 billion - statnews.com

Tue, 31 Mar 2026 07:00:00 GMT

Biogen to acquire immunology biotech Apellis for $5.6 billion statnews.com

Is It Time To Reconsider Biogen (BIIB) After Its 50% One Year Share Price Jump - Yahoo Finance

Sat, 11 Apr 2026 07:00:00 GMT

Is It Time To Reconsider Biogen (BIIB) After Its 50% One Year Share Price Jump Yahoo Finance

Why Biogen (BIIB) Could Beat Earnings Estimates Again - Yahoo Finance

Tue, 07 Apr 2026 07:00:00 GMT

Why Biogen (BIIB) Could Beat Earnings Estimates Again Yahoo Finance

Biogen and Stoke Therapeutics Present New Data at the 54th Child Neurology Society (CNS) Annual Meeting that Support the Potential of Zorevunersen as a Disease-Modifying Medicine for Dravet Syndrome - Biogen

Thu, 09 Oct 2025 07:00:00 GMT

Biogen and Stoke Therapeutics Present New Data at the 54th Child Neurology Society (CNS) Annual Meeting that Support the Potential of Zorevunersen as a Disease-Modifying Medicine for Dravet Syndrome Biogen

Inside Biogen’s West Coast Hub: Building an Innovation Engine - Biogen

Tue, 18 Nov 2025 08:00:00 GMT

Inside Biogen’s West Coast Hub: Building an Innovation Engine Biogen

Biogen Beats Q1 Earnings Estimates but Cuts 2026 EPS View on M&A Costs - Yahoo Finance

Wed, 29 Apr 2026 07:00:00 GMT

Biogen Beats Q1 Earnings Estimates but Cuts 2026 EPS View on M&A Costs Yahoo Finance